Previously, a study utilizing whole section slides for TILs, which were assessed with QuPath in cases of HER2-negative breast cancer, showed that the density of CD8 + TILs was higher in the invasive margin as compared to the tumor center, and the scoring results with QuPath correlated strongly with the manual counting values [34]. The gene discussed is ERBB2; the disease is breast carcinoma.